Objective: To evaluate the effect of Transcutaneous auricular vagus nerve stimulation for the patients Meniere disease. Methods: We accrued 25 patients at Beijing TongRen Hospital. All treatments were self-administered by the patients at home after training at the hospital. Patients completed questionnaires at baseline and after 4 weeks, 8 weeks, 12 weeks. Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry, visual scale of ear stuffiness and SF-36 were performed to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean change from Baseline in the Tinnitus Handicap Inventory (THI) rating scale at 12 Weeks
Timeframe: Day 0 and postintervention at Week 12
Mean change from Baseline in the Dizziness Handicap Inventory (DHI) at 12 Weeks
Timeframe: Day 0 and postintervention at Week 12
Mean change from Baseline in the Pure Tone Audiometry at 12 Weeks
Timeframe: Day 0 and postintervention at Week 12